Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients
Danay Saavedra, Beatriz García Verdecia, Patricia Lorenzo-Luaces, et al.
Cancer Immunology Immunotherapy (2015) Vol. 65, Iss. 1, pp. 37-45
Closed Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Senescent T cells: a potential biomarker and target for cancer therapy
Jie Zhang, Tianhui He, Lixiang Xue, et al.
EBioMedicine (2021) Vol. 68, pp. 103409-103409
Open Access | Times Cited: 108
Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter?
Roberto Ferrara, Laura Mezquita, Édouard Auclin, et al.
Cancer Treatment Reviews (2017) Vol. 60, pp. 60-68
Open Access | Times Cited: 149
Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency
Antero Salminen, Kai Kaarniranta, Anu Kauppinen
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 10, pp. 1901-1918
Open Access | Times Cited: 123
Circulating T-cell Immunosenescence in Patients with Advanced Non–small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy
Roberto Ferrara, Marie Naigeon, Édouard Auclin, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 2, pp. 492-503
Open Access | Times Cited: 121
Therapeutic vaccines for advanced non-small cell lung cancer
Marcela Cortés-Jofré, Mikel Rueda-Etxebarria, Émeline Orillard, et al.
Cochrane library (2024) Vol. 2024, Iss. 3
Closed Access | Times Cited: 8
CIMAvax-EGF: A New Therapeutic Vaccine for Advanced Non-Small Cell Lung Cancer Patients
Danay Saavedra, Tania Crombet
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 72
Does Regular Exercise Counter T Cell Immunosenescence Reducing the Risk of Developing Cancer and Promoting Successful Treatment of Malignancies?
James Turner, Patrı́cia C. Brum
Oxidative Medicine and Cellular Longevity (2017) Vol. 2017, Iss. 1
Open Access | Times Cited: 54
A Subset of PD-1-Expressing CD56bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer
Marta Gascón Ruiz, Ariel Ramírez-Labrada, Rodrigo Pimienta Lastra, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 329-329
Open Access | Times Cited: 13
Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy
Katarzyna Tomela, Bernadeta Pietrzak, Łukasz Galus, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 789-789
Open Access | Times Cited: 13
Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy
Chao Liu, Shikai Wu, Xiangying Meng, et al.
Oncotarget (2017) Vol. 8, Iss. 26, pp. 43427-43438
Open Access | Times Cited: 40
Triple combination immunotherapy with GVAX, anti-PD-1 monoclonal antibody, and agonist anti-OX40 monoclonal antibody is highly effective against murine intracranial glioma
Nusrat Jahan, Hammad Talat, Andrea Alonso, et al.
OncoImmunology (2019) Vol. 8, Iss. 5, pp. e1577108-e1577108
Open Access | Times Cited: 40
Senescence markers: Predictive for response to checkpoint inhibitors
Alvaro Moreira, Stefanie Groß, Michael C. Kirchberger, et al.
International Journal of Cancer (2018) Vol. 144, Iss. 5, pp. 1147-1150
Open Access | Times Cited: 39
Age-related changes in T lymphocytes of patients with head and neck squamous cell carcinoma
S Jeske, Patrick J. Schuler, Johannes Doescher, et al.
Immunity & Ageing (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 34
Polyfunctional KLRG-1+CD57+ Senescent CD4+ T Cells Infiltrate Tumors and Are Expanded in Peripheral Blood From Breast Cancer Patients
María C. Ramello, Nicolás Gonzalo Núñez, Jimena Tosello, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 28
Biomarkers of response to immunotherapy in early stage non-small cell lung cancer
Matthieu Roulleaux Dugage, Víctor Albarrán-Artahona, Juan Carlos Laguna, et al.
European Journal of Cancer (2023) Vol. 184, pp. 179-196
Closed Access | Times Cited: 12
Peripheral changes in T cells predict efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer
Juanfeng Lao, Huiting Xu, Zibin Liang, et al.
Immunobiology (2023) Vol. 228, Iss. 3, pp. 152391-152391
Open Access | Times Cited: 11
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8 + T cells in patients with advanced NSCLC
Marie Naigeon, Matthieu Roulleaux Dugage, François‐Xavier Danlos, et al.
Science Advances (2023) Vol. 9, Iss. 45
Open Access | Times Cited: 11
A nomogram for predicting cancer-related cognitive impairment in lung cancer patients from a nursing science precision health model perspective
Lei Ye, Xiaoyu Xu, Lijuan Liu, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 4
Closed Access
Integrating cuproptosis and immunosenescence: A novel therapeutic strategy in cancer treatment
Ali Ahmadizad Firouzjaei, Seyed Hamid Aghaee‐Bakhtiari
Biochemistry and Biophysics Reports (2025) Vol. 42, pp. 101983-101983
Closed Access
Two weeks of hydrogen inhalation can significantly reverse adaptive and innate immune system senescence patients with advanced non-small cell lung cancer: a self-controlled study
Kecheng Xu, Jibing Chen, Xiaofeng Kong, et al.
Medical Gas Research (2020) Vol. 10, Iss. 4, pp. 149-149
Open Access | Times Cited: 27
Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer
Boris Duchemann, Jordi Remón, Marie Naigeon, et al.
Translational Lung Cancer Research (2021) Vol. 10, Iss. 6, pp. 2937-2954
Open Access | Times Cited: 23
Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma
Marius Ilié, Mélanie Beaulande, Saima Ben Hadj, et al.
Cancers (2018) Vol. 10, Iss. 9, pp. 326-326
Open Access | Times Cited: 27
T Cell Subpopulations in Healthy Elderly and Lung Cancer Patients: Insights from Cuban Studies
Danay Saavedra, Beatriz García Verdecia, Agustín Lage
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 23
CIMAvax-EGF: Toward long-term survival of advanced NSCLC
Danay Saavedra, Elia Neninger, Camilo Rodríguez, et al.
Seminars in Oncology (2018) Vol. 45, Iss. 1-2, pp. 34-40
Open Access | Times Cited: 23
Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression
Yingyi Wang, Na Zhou, Rui Zhu, et al.
BMC Pulmonary Medicine (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top